CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $64,000 | -63.2% | 53,447 | -16.7% | 0.01% | -66.7% |
| Q4 2021 | $174,000 | -63.1% | 64,126 | -39.3% | 0.02% | -56.1% |
| Q3 2021 | $471,000 | -52.8% | 105,562 | -38.6% | 0.04% | -57.7% |
| Q2 2021 | $998,000 | +101.2% | 171,994 | +102.2% | 0.10% | +14.1% |
| Q3 2020 | $496,000 | +93.8% | 85,075 | +246.2% | 0.08% | +240.0% |
| Q4 2019 | $256,000 | +19.1% | 24,572 | +183.4% | 0.02% | +108.3% |
| Q1 2019 | $215,000 | -68.2% | 8,669 | +5.6% | 0.01% | -63.6% |
| Q3 2017 | $676,000 | – | 8,209 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,200,000 | 4.04% |
| Palo Alto Investors LP | 4,469,411 | $21,453,000 | 1.12% |
| ARMISTICE CAPITAL, LLC | 2,256,000 | $10,829,000 | 0.37% |
| Vigilare Wealth Management | 32,200 | $155,000 | 0.15% |
| Ikarian Capital, LLC | 650,000 | $3,121,000 | 0.14% |
| Ikarian Capital, LLC | 642,108 | $3,082,000 | 0.14% |
| WELD CAPITAL MANAGEMENT LLC | 40,156 | $193,000 | 0.08% |
| PINNACLE ASSOCIATES LTD | 703,970 | $3,379,000 | 0.07% |
| Versant Venture Management, LLC | 101,855 | $489,000 | 0.05% |
| Kalos Management, Inc. | 23,750 | $114,000 | 0.05% |